Organization
MS Canada
- Meetings this Parliament
- 31
- With MPs
- 19
- Since Nov 2021
- 147
- Active registrations
- 1
Most recent reported meeting: Sep 29, 2026.
Lobbying by MS Canada: its registrations, its lobbyists, the bills it has named and every meeting it has reported with federal office holders since November 2021.
← LobbyingOrganization
Most recent reported meeting: Sep 29, 2026.
In-house (organization) In effect since Aug 24, 2026 Receives government funding
Filed by Pamela Valentine, President & CEO
Institutions they may lobby: Accessibility Standards Canada, Atlantic Canada Opportunities Agency (ACOA), Canada Employment Insurance Commission, Canada Post Corporation (CPC), Canada Revenue Agency (CRA), Canadian Heritage (PCH), Canadian Human Rights Commission (CHRC), Canadian Institutes of Health Research (CIHR), Canadian Transportation Agency (CTA), Employment and Social Development Canada (ESDC), Finance Canada (FIN), Global Affairs Canada (GAC), Health Canada (HC), House of Commons, Innovation, Science and Economic Development Canada (ISED), Office of the Commissioner of Lobbying (OCL), Office of the Federal Housing Advocate, Office of the Information Commissioner of Canada (OIC), Office of the Privacy Commissioner of Canada (OPC), Patented Medicine Prices Review Board (PMPRB), Prime Minister's Office (PMO), Privy Council Office (PCO), Public Health Agency of Canada (PHAC), Public Services and Procurement Canada (PSPC), Rural Economic Development (Minister’s Office), Senate of Canada, Service Canada (ServCan), Social Sciences and Humanities Research Council (SSHRC), Statistics Canada (StatCan), Transport Canada (TC), Treasury Board Of Canada Secretariat (TBS), Veterans Affairs Canada (VAC), Women and Gender Equality (WAGE)
Registration 935976-14937-87. Look it up in the official Registry
Reported by Pamela Valentine · In-house (organization)
Disability Tax Credit with respect to making it refundable and ensuring eligibility for Canadians with episodic disabilities
Reported by Pamela Valentine · In-house (organization)
We ask the federal government to fund MS research in partnership with MS Canada, leveraging our connections and expertise to focus and further our understanding of MS, pursue leading-edge research on repair and regeneration, and explore prevention strategies, including targeting the Epstein-Barr virus (EBV).
Reported by Pamela Valentine · In-house (organization)
Reported by Pamela Valentine · In-house (organization)
Canada Disability Benefit Regulations, with respect to creating a benefit that can be accessed by Canadians with episodic disabilities and lifts Canadians with disabilities out of poverty
Disability Tax Credit with respect to making it refundable and ensuring eligibility for Canadians with episodic disabilities
Comprehensive disability income programs, with respect to persons with MS and other chronic and episodic disabilities
Reported by Pamela Valentine · In-house (organization)
Federal Budget: Allocate funding for the Canada Disability Benefit, the Employment Insurance Sickness Benefit; health research; access to treatment and care; and other budgetary policy as it relates to MS.
Reported by Pamela Valentine · In-house (organization)
Reported by Pamela Valentine · In-house (organization)
Canada Health Act and regulations, as it relates to long-term and home care
CIHR as it relates to federal funding & long term investment in health research
Federal Budget: Allocate funding for the Canada Disability Benefit, the Employment Insurance Sickness Benefit; health research; access to treatment and care; and other budgetary policy as it relates to MS.
Access to treatments as it relates to the current regulatory and price negotiation processes to enhance timely access to all Health Canada approved MS disease-modifying therapies, with respect to the National Strategy for Drugs for Rare Diseases and national pharmacare.
Reported by Pamela Valentine · In-house (organization)
Reported by Pamela Valentine · In-house (organization)
Reported by Pamela Valentine · In-house (organization)
Canada Disability Benefit Regulations, with respect to creating a benefit that can be accessed by Canadians with episodic disabilities and lifts Canadians with disabilities out of poverty
Canada Pension Plan – Disability with respect to eligibility for persons with MS and other chronic and episodic disabilities
CIHR as it relates to federal funding & long term investment in health research
Reported by Pamela Valentine · In-house (organization)
CIHR as it relates to federal funding & long term investment in health research
Disability Tax Credit with respect to making it refundable and ensuring eligibility for Canadians with episodic disabilities
Reported by Pamela Valentine · In-house (organization)
Federal Budget: Allocate funding for the Canada Disability Benefit, the Employment Insurance Sickness Benefit; health research; access to treatment and care; and other budgetary policy as it relates to MS.
We ask the federal government to fund MS research in partnership with MS Canada, leveraging our connections and expertise to focus and further our understanding of MS, pursue leading-edge research on repair and regeneration, and explore prevention strategies, including targeting the Epstein-Barr virus (EBV).
Disability Tax Credit with respect to making it refundable and ensuring eligibility for Canadians with episodic disabilities
Reported by Pamela Valentine · In-house (organization)
Canada Disability Benefit Regulations, with respect to creating a benefit that can be accessed by Canadians with episodic disabilities and lifts Canadians with disabilities out of poverty
Disability Tax Credit with respect to making it refundable and ensuring eligibility for Canadians with episodic disabilities
We ask the federal government to fund MS research in partnership with MS Canada, leveraging our connections and expertise to focus and further our understanding of MS, pursue leading-edge research on repair and regeneration, and explore prevention strategies, including targeting the Epstein-Barr virus (EBV).
Reported by Pamela Valentine · In-house (organization)
Reported by Pamela Valentine · In-house (organization)
Federal Budget: Allocate funding for the Canada Disability Benefit, the Employment Insurance Sickness Benefit; health research; access to treatment and care; and other budgetary policy as it relates to MS.
CIHR as it relates to federal funding & long term investment in health research
Reported by Pamela Valentine · In-house (organization)
BudgetHealthResearch and DevelopmentTaxation and Finance
Reported by Pamela Valentine · In-house (organization)
Employment and TrainingTaxation and Finance
Reported by Pamela Valentine · In-house (organization)
BudgetHealthResearch and DevelopmentTaxation and Finance
Reported by Pamela Valentine · In-house (organization)
BudgetHealthResearch and DevelopmentTaxation and Finance
Reported by Pamela Valentine · In-house (organization)
BudgetHealthResearch and DevelopmentTaxation and Finance
Reported by Pamela Valentine · In-house (organization)
BudgetHealthResearch and Development
Reported by Pamela Valentine · In-house (organization)
Research and Development
Reported by Pamela Valentine · In-house (organization)
BudgetEmployment and TrainingHealthHousingLabourResearch and DevelopmentScience and TechnologyTaxation and Finance
Reported by Pamela Valentine · In-house (organization)
BudgetEmployment and TrainingHealthHousingResearch and DevelopmentScience and TechnologyTaxation and Finance
Reported by Pamela Valentine · In-house (organization)
HealthResearch and DevelopmentTaxation and Finance
From the Office of the Commissioner of Lobbying's open data, published November 5, 2026. Reports cover oral, arranged meetings with designated public office holders since November 22, 2021; lobbyists file them by the 15th of the following month. Names of MPs are matched to the current House of Commons, and bills are linked when the lobbyist's own description makes clear which bill it means. Contains information licensed under the Open Data Licence Agreement — Office of the Commissioner of Lobbying. Licence. PolitiKit is independent and is not endorsed by the Commissioner of Lobbying.